PDL BioPharma, Inc. (PDLI) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Total non-operating expense, net: -4.35M
Today's EPS Names:
NSLR, OCTV, ACB, More
Financial Fact:
Total non-operating expense, net: -4.35M
Today's EPS Names:
NSLR, OCTV, ACB, More
Join SI Premium – FREE
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q2 adjusted EPS of $0.39, $0.01 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $122.1 million versus the consensus estimate of $123.25 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Brinker International (EAT) Misses Q4 EPS by 2c ; Offers Guidance
- Riskified Ltd. (RSKD) Reports In-Line Q2 EPS ; Offers Guidance
- TECO Energy (TE) Reports Q2 Loss of $0.14
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
